H. Lawrence  Remmel net worth and biography

H. Lawrence Remmel Biography and Net Worth

Director of Atossa Genetics

Mr. Remmel has served as a director of the Company since February 2012. He is currently a partner of the law firm Pryor Cashman LLP, located in New York City, where he chairs the Banking and Finance practice group. Mr. Remmel joined Pryor Cashman in 1988. His practice includes corporate and banking financings, issues relating to the Investment Company Act of 1940, and intellectual property and licensing issues, in particular in the biotechnology and biocosmeceutical areas.

How do I contact H. Lawrence Remmel?

The corporate mailing address for Mr. Remmel and other Atossa Genetics executives is 1448 NW Market Street, Suite 500, Seattle, WA, 98107. Atossa Genetics can also be reached via phone at (206) 588-0256 and via email at [email protected]. Learn More on H. Lawrence Remmel's contact information.

Has H. Lawrence Remmel been buying or selling shares of Atossa Genetics?

H. Lawrence Remmel has not been actively trading shares of Atossa Genetics during the last quarter. Learn More on H. Lawrence Remmel's trading history.

Who are Atossa Genetics' active insiders?

Atossa Genetics' insider roster includes H. Lawrence Remmel (Director), and Gregory Weaver (Director). Learn More on Atossa Genetics' active insiders.

H. Lawrence Remmel Insider Trading History at Atossa Genetics

See Full Table

H. Lawrence Remmel Buying and Selling Activity at Atossa Genetics

This chart shows H. Lawrence Remmel's buying and selling at Atossa Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Atossa Genetics Company Overview

Atossa Genetics logo
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $2.29
Low: $1.96
High: $2.30

50 Day Range

MA: $2.39
Low: $1.90
High: $2.79

2 Week Range

Now: $2.29
Low: $1.70
High: $19.35

Volume

88,161 shs

Average Volume

117,033 shs

Market Capitalization

$22.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27